SCHEMBL8143522

SCHEMBL8143522

COc1cc(OC)cc(-c2cnc3cc4cn[nH]c4cc3n2)c1.COc1cccc(OC)c1-c1cnc2cc3[nH]ncc3cc2n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ TLR8 Q9NR97 1/20 0.42
▸ PDGFRB P09619 1/20 0.40
▸ PDGFRA P16234 1/20 0.40
▸ MAP3K11 Q16584 3/20 0.39
▸ AXL P30530 1/20 0.39
▸ ATR Q13535 1/20 0.38
▸ FGFR1 P11362 2/20 0.38
▸ FGFR2 P21802 2/20 0.38
▸ FGFR3 P22607 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ KDR P35968 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616668 0.91 ALDH1A1 (0.47) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6618812 0.91 ALDH1A1 (0.47) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6618516 0.89 GAA (0.44) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6622035 0.89 GAA (0.44) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6616674 0.84 FGFR1 (0.48) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6620076 0.84 FGFR1 (0.48) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6618338 0.81 MAPK1 (0.51) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6617606 0.81 MAPK1 (0.51) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL8112499 0.81 MAPK1 (0.51) GAAMAPTALDH1A1GLASMN1; SMN2
SCHEMBL6618374 0.78 MAP3K11 (0.55) GAAMAPTALDH1A1GLASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 — — EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
Send feedback